deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT04728633

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Chemoembolization of Uveal Melanoma Hepatic Metastases Using 300mg of BCNU Dissolved in Lipiodol® Followed by Gelfoam® Embolization

Sponsor: Thomas Jefferson University

Conditions Metastatic Malignant Neoplasm in the Liver Metastatic Uveal Melanoma Stage IV Choroidal and Ciliary Body Melanoma AJCC V8
Interventions Carmustine Ethiodized Oil Medical Device Usage and Evaluation Transarterial Chemoembolization
Updated 11 times since 2021 Last updated: Aug 1, 2025 Started: Sep 27, 2021 Primary completion: Jan 31, 2027 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Metastatic Malignant Neoplasm in the Liver and Metastatic Uveal Melanoma and is currently ongoing. Thomas Jefferson University leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshotNot Yet Recruiting~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Dec 2022 · 13 months · monthly snapshotRecruiting~Dec 2022 – ~Aug 2023 · 8 months · monthly snapshotRecruiting~Aug 2023 – ~Nov 2023 · 3 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Mar 2025 · 4 months · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotActive Not Recruiting~Sep 2025 – present · 10 months · monthly snapshotActive Not Recruiting

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Mar 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Nov 2024 — Mar 2025 [monthly]

    Recruiting PHASE2

  4. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

▶ Show 6 earlier versions

  1. Nov 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

  2. Aug 2023 — Nov 2023 [monthly]

    Recruiting PHASE2

  3. Dec 2022 — Aug 2023 [monthly]

    Recruiting PHASE2

  4. Nov 2021 — Dec 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Sep 2021 — Nov 2021 [monthly]

    Not Yet Recruiting PHASE2

  6. Feb 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Thomas Jefferson University
Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations